NEW HIGHLIGHT
Vizimpro

Vizimpro Indications/Uses

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations [see Patient Selection under Dosage & Administration].
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in